Shares of Spectral Medical Inc. (OTCMKTS:EDTXF – Get Free Report) traded up 1.8% during trading on Wednesday . The stock traded as high as $0.52 and last traded at $0.52. 7,700 shares traded hands during mid-day trading, a decline of 44% from the average session volume of 13,844 shares. The stock had previously closed at $0.52.
Spectral Medical Stock Performance
The company has a market capitalization of $149.46 million, a price-to-earnings ratio of -7.50 and a beta of 0.84. The company has a fifty day simple moving average of $0.44 and a two-hundred day simple moving average of $0.42.
Spectral Medical Company Profile
Spectral Medical Inc focuses on the development and commercialization of products for the treatment of septic shock in the United States, Italy, Ireland, and internationally. The company markets Endotoxin Activity Assay, a rapid in vitro diagnostic test for the detection of components of gram negative bacterial cell wall; and Polymyxin B Hemoperfusion, a therapeutic hemoperfusion device that removes endotoxin from the bloodstream.
Featured Articles
- Five stocks we like better than Spectral Medical
- What is a penny stock? A comprehensive guide
- Energy Transfer: Powering Data With Dividends and Diversification
- EV Stocks and How to Profit from Them
- Qualcomm Stock Is Coiling for a Breakout
- How to Use the MarketBeat Dividend Calculator
- Is Alphabet Too Cheap to Ignore After Its Recent Correction?
Receive News & Ratings for Spectral Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Spectral Medical and related companies with MarketBeat.com's FREE daily email newsletter.
